Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107723883 | 10772388 | 3 | F | 20150128 | 20160914 | 20150207 | 20160927 | EXP | CA-UCBSA-2015003487 | UCB | 59.49 | YR | M | Y | 0.00000 | 20160927 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107723883 | 10772388 | 1 | PS | Certolizumab pegol RA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 400 MG, EV 2 WEEKS(QOW) | Y | U | 125160 | 400 | MG | SOLUTION FOR INJECTION | QOW | ||||
| 107723883 | 10772388 | 2 | SS | Certolizumab pegol RA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 200 MG, EV 2 WEEKS(QOW) | Y | U | 125160 | 200 | MG | SOLUTION FOR INJECTION | QOW | ||||
| 107723883 | 10772388 | 3 | SS | Atorvastatin | ATORVASTATIN | 1 | UNK | Y | U | 0 | |||||||||
| 107723883 | 10772388 | 4 | C | METHOTREXATE. | METHOTREXATE | 1 | UNK | Y | U | 0 | |||||||||
| 107723883 | 10772388 | 5 | C | METOPROLOL. | METOPROLOL | 1 | UNK | U | 0 | ||||||||||
| 107723883 | 10772388 | 6 | C | RAMIPRIL. | RAMIPRIL | 1 | UNK | U | 0 | ||||||||||
| 107723883 | 10772388 | 7 | C | Asa | ASPIRIN | 1 | UNK | U | 0 | ||||||||||
| 107723883 | 10772388 | 8 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | U | 0 | |||||||||||
| 107723883 | 10772388 | 9 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | U | 0 | |||||||||||
| 107723883 | 10772388 | 10 | C | ATROVENT | IPRATROPIUM BROMIDE | 1 | U | 0 | |||||||||||
| 107723883 | 10772388 | 11 | C | PREDNISONE. | PREDNISONE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107723883 | 10772388 | 1 | Rheumatoid arthritis |
| 107723883 | 10772388 | 3 | Product used for unknown indication |
| 107723883 | 10772388 | 4 | Product used for unknown indication |
| 107723883 | 10772388 | 5 | Product used for unknown indication |
| 107723883 | 10772388 | 6 | Product used for unknown indication |
| 107723883 | 10772388 | 7 | Product used for unknown indication |
| 107723883 | 10772388 | 8 | Pneumonia |
| 107723883 | 10772388 | 9 | Pneumonia |
| 107723883 | 10772388 | 10 | Pneumonia |
| 107723883 | 10772388 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107723883 | 10772388 | OT |
| 107723883 | 10772388 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107723883 | 10772388 | Arthritis | |
| 107723883 | 10772388 | Pneumonia | |
| 107723883 | 10772388 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107723883 | 10772388 | 1 | 20120411 | 20120509 | 0 | |
| 107723883 | 10772388 | 2 | 20120523 | 201501 | 0 |